Y Guo, D Cui. Show Affiliations »
Abstract
Entities: Disease
Mesh: See more » Antitubercular Agents/adverse effectsAntitubercular Agents/therapeutic useChemical and Drug Induced Liver Injury/etiologyHumansIsoniazid/adverse effectsIsoniazid/therapeutic useRifampin/adverse effectsRifampin/therapeutic useTuberculosis/drug therapy
Substances: See more » Antitubercular AgentsIsoniazidRifampin
Year: 1998 PMID: 11326960
Source DB: PubMed Journal: Zhonghua Jie He He Hu Xi Za Zhi ISSN: 1001-0939